Johnson & Johnson (JNJ) Cash from Investing Activities (QoQ) (2009 - 2026)

Johnson & Johnson (JNJ) Cash from Investing Activities (QoQ) (2009 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Gsk	96,436,181.12 Bn	96,436,176.16 Bn	7.76 Bn
2	Eli Lilly	1,017.30 Bn	1,012.01 Bn	16.22 Bn
3	Johnson & Johnson	579.61 Bn	557.55 Bn	15.96 Bn
4	AbbVie	402.30 Bn	392.96 Bn	10.78 Bn
5	Merck	294.24 Bn	288.59 Bn	12.09 Bn
6	Amgen	191.82 Bn	179.78 Bn	5.87 Bn
7	Gilead Sciences	155.93 Bn	148.21 Bn	5.52 Bn
8	Pfizer	149.05 Bn	136.28 Bn	-1.21 Bn
9	Bristol Myers Squibb	116.33 Bn	105.88 Bn	8.07 Bn
10	Novartis Ag	112.59 Bn	111.90 Bn	-

Download Data